Market Closed -
Other stock markets
|
After hours 19:55:43 | |||
302.91 USD | -1.56% |
|
302.23 | -0.22% |
07-09 | Health Care Climbs After Verona Deal - Health Care Roundup | DJ |
07-09 | Wall Street rises as Fed minutes put rate cuts in focus, Nvidia hits $4 trillion milestone | RE |
Summary: UnitedHealth Group Inc.
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- According to MSCI, the company's ESG score for its industry is good.
Highlights: UnitedHealth Group Inc.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.72 for the current period. Therefore, the company is undervalued.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses: UnitedHealth Group Inc.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings Chart: UnitedHealth Group Inc.
Source: Surperformance
ESG chart: UnitedHealth Group Inc.
Source: MSCI
Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
---|---|---|---|---|---|
279B | |||||
83.35B | |||||
78.96B | |||||
28.66B | |||||
16.22B | |||||
12.52B | |||||
- | 2.71B | ||||
2.08B | |||||
- | 1.55B | ||||
Average | 56.13B | ||||
Weighted average by Cap. |
Investor (Composite)
Trader (Composite)
ESG MSCI
BBB
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
Valuation
P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
ESG
Environment
Social
Governance
Controversy
Ethical controversies
Human rights controversies
Tax subsidies controversies
Sharia compliant
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- UNH Stock
- Ratings UnitedHealth Group Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition